Comparison of various surgical approaches for extensive bilateral colorectal liver metastases

被引:10
作者
Reissfelder, Christoph [1 ,4 ]
Rahbari, Nuh N. [1 ,3 ]
Bejarano, L. Urrutia [1 ]
Schmidt, Thomas [1 ]
Kortes, Nikolas [2 ]
Kauczor, Hans-Ulrich [2 ]
Buechler, Markus W. [1 ]
Weitz, Juergen [1 ,3 ]
Koch, Moritz [1 ,3 ]
机构
[1] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[2] Heidelberg Univ, Dept Radiol, Heidelberg, Germany
[3] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, D-01307 Dresden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, D-01307 Dresden, Germany
关键词
Staged hepatic resection; Portal vein embolization; Radio frequency ablation; Mortality; Morbidity; Survival; PORTAL-VEIN EMBOLIZATION; LONG-TERM SURVIVAL; HEPATIC RESECTION; 2-STAGE HEPATECTOMY; RADIOFREQUENCY ABLATION; CANCER; CHEMOTHERAPY; OUTCOMES; TUMORS; HYPERTROPHY;
D O I
10.1007/s00423-014-1177-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Tailored operative strategies have been proposed for patients with bilobar colorectal liver metastases (CLM). The aim of the study was to evaluate the long-term outcome, safety and efficacy, including cancer-specific survival, morbidity, and mortality, of three different surgical strategies for extensive bilateral CLM. This is a retrospective study of a prospective database of 356 consecutive patients, who underwent hepatic resection due to CLM between January 2003 and January 2009. Fifty-nine patients underwent three different therapeutic approaches: 22 patients with portal vein embolization (PVE) + staged resections, 11 patients with staged resections solely, and 26 patients with an extensive liver resection and simultaneous or subsequent radiofrequency ablation (RFA). The three groups were comparable regarding their general patient characteristics. The overall morbidity and mortality rates were 27.1 and 1.7 %, respectively. There were no significant differences in morbidity, mortality, or survival between the three groups. The median survival of all patients was 48 months, with a recurrence-free survival of 30 months. The clearance of bilobar CLM can be achieved by various strategies, all of them providing an acceptable mortality rate and survival for the patients. Therefore, patients with bilobar liver metastases should receive a procedure tailored for their individual extent of disease.
引用
收藏
页码:481 / 491
页数:11
相关论文
共 27 条
[1]   Chemotherapy prior to Hepatic Resection for Colorectal Liver Metastases: Helpful until Harmful? [J].
Abdalla, Eddie K. ;
Vauthey, Jean-Nicolas .
DIGESTIVE SURGERY, 2008, 25 (06) :421-429
[2]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[3]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[4]   Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors [J].
Adam, R ;
Laurent, A ;
Azoulay, D ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (06) :777-784
[5]   Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases [J].
Aloia, Thomas ;
Sebagh, Mylene ;
Plasse, Marylene ;
Karam, Vincent ;
Levi, Francis ;
Giacchetti, Sylvie ;
Azoulay, Daniel ;
Bismuth, Henri ;
Castaing, Denis ;
Adam, Rene .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :4983-4990
[6]   Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization [J].
Azoulay, D ;
Castaing, D ;
Smail, A ;
Adam, R ;
Cailliez, V ;
Laurent, A ;
Lemoine, A ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 231 (04) :480-486
[7]   High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome [J].
Brouquet, Antoine ;
Abdalla, Eddie K. ;
Kopetz, Scott ;
Garrett, Christopher R. ;
Overman, Michael J. ;
Eng, Cathy ;
Andreou, Andreas ;
Loyer, Evelyne M. ;
Madoff, David C. ;
Curley, Steven A. ;
Vauthey, Jean-Nicolas .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) :1083-1090
[8]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[9]   Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases [J].
Chun, Yun Shin ;
Vauthey, Jean-Nicolas ;
Boonsirikamchai, Piyaporn ;
Maru, Dipen M. ;
Kopetz, Scott ;
Palavecino, Martin ;
Curley, Steven A. ;
Abdalla, Eddie K. ;
Kaur, Harmeet ;
Charnsangavej, Chusilp ;
Loyer, Evelyne M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21) :2338-2344
[10]  
Chung H, 2007, HEPATO-GASTROENTEROL, V54, P701